Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 7,407 | 11,508 | 0 |
| Marketable Securities | 0 | 0 | 19,553 | 23,127 | 0 |
| Other current assets | 0 | 0 | 697 | 602 | 0 |
| TOTAL | $0 | $0 | $27,657 | $35,237 | $0 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 7,341 | 8,519 | 0 |
| Other Non-Current Assets | 0 | 0 | 1,518 | 994 | 0 |
| TOTAL | $0 | $0 | $8,859 | $9,513 | $0 |
| Total Assets | $0 | $0 | $36,515 | $44,751 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 1,343 | 1,343 | 0 |
| Accounts payable and accrued liabilities | 0 | 0 | 958 | 1,783 | 0 |
| Accrued Expenses | 0 | 0 | 986 | 780 | 0 |
| TOTAL | $0 | $0 | $3,286 | $3,906 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 3,802 | 5,145 | 0 |
| TOTAL | $0 | $0 | $3,802 | $5,145 | $0 |
| Total Liabilities | $0 | $0 | $7,089 | $9,051 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 14 | 13 | 0 |
| Retained earnings | 0 | 0 | -19,460 | -6,890 | 0 |
| Other shareholders' equity | 0 | 0 | 0 | 1 | 0 |
| TOTAL | $0 | $0 | $29,427 | $35,700 | $0 |
| Total Liabilities And Equity | $0 | $0 | $36,516 | $44,751 | $0 |